Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Pediatrix Medical Group Q3 2026 Results: Net Income $47M, Down 34.5% YoY

Pediatrix Medical Group reported net revenue of $501.4 million for the quarter ended September 30, 2026, a slight increase from $492.9 million in the prior year. Net income for the quarter decreased to $47.0 million from $71.7 million, primarily due to a $20.9 million gain on divested businesses in 2025 that did not recur. The company significantly increased its share repurchase activity, spending $147.2 million during the first nine months of 2026.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue501.4492.9
Profit before tax65.087.8
Net income47.071.7
EPS (diluted, $ a share)$0.59$0.84

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year-34.5%
Revenue, year on year+1.7%
Operating margin13.0%
Source

10-Q filed with the SEC, NYSE: MD. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Pediatrix Medical Group, Inc.: key numbers

Share price
$31.13Close, Nov 17
Market cap
$2.43B
Shares outstanding
78.12MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-HospitalsSIC 8060

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Pediatrix Medical Group, Inc.

All →
6:51 AM ET 8-K
Financial Results

Pediatrix Medical Group Financial Results

Pediatrix Medical Group reported Q3 2026 net revenue of $501.4 million and net income of $47 million, or $0.59 per share. The results were driven by a 1.7% increase in net revenue reflecting growth in both same-unit and non-same unit activity, alongside a favorable shift in payor mix.

Term
Q3 2026

“We are pleased with our results this quarter, driven by both volume and pricing performing ahead of our expectations. We continue to push operating efficiency paired with sector leading care quality, while considering high-value opportunities in adjacent businesses, as they arise.”

Mark S. Ordan, Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.